Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01289587
Other study ID # 252/10
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2011
Est. completion date October 2017

Study information

Verified date March 2020
Source University of Lausanne Hospitals
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the effects of a physical activity intervention in patients with type 2 diabetes in a community setting.


Description:

The aim of this study is

1. to evaluate the effects (before and after) of a physical activity program (DIAfit program) which contains 36 sessions of structured PA and also encourages unstructured PA in an unselected population of patients with type 2 diabetes independent of the selected variant of the program

2. to compare the effects of a standard DIAfit program (3 times per week for 12 weeks) with and alternative program which suggests a more progressive PA activity intensity (starting with one PA session per week during 4 weeks and then twice a week over a period of 16 more weeks (20 weeks total). In total the program also consist of 36 sessions)


Recruitment information / eligibility

Status Completed
Enrollment 185
Est. completion date October 2017
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of type 2 diabetes

Exclusion Criteria:

- Orthopedic complications

- Diabetic foot ulceration

- "Active " cardiac (ischemia during the exercise test) or stade III peripheral vascular disease

- Untreated proliferative retinopathy

- Autonomic neuropathy

- Active psychiatric, neurological, orthopedic, muscular or rheumatic disease interfering with a participation in a physical activity program

- Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Physical activity intervention
36 sessions of physical activity offered at different frequencies

Locations

Country Name City State
Switzerland University of Lausanne Hospitals Lausanne

Sponsors (2)

Lead Sponsor Collaborator
University of Lausanne Hospitals University Hospital, Geneva

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Aerobic fitness Change in aerobic fitness End of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary Body composition Change in body composition At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary BMI Change in BMI At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary HbA1c Change in HbA1c At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary Lipid values Change in Lipid values At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary Motor performance Change in motor performance At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary Physical activity Change in physical activity At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary Well-being Change in well-being (validated questionnaire) At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary Self-efficacy Change in self-efficacy (questionnaire) At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary Qualitative evaluation (satisfaction of achievement of personal objectives, evaluation of group session) At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Secondary Adherence/Attendance: Number of physical activity sessions attended During the intervention
See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4

External Links